Ovagen
Also known as: Liver Bioregulator, Khavinson Liver Peptide, GluAlaAspLys
Ovagen is a tetrapeptide bioregulator developed as a liver and gastrointestinal tract-specific cytoprotective and anti-aging agent. It belongs to the same family of short peptide bioregulators (Cytomaxes) as Epithalon and Vilon. Backed by over 40 years of Russian clinical research, Ovagen is studied for its ability to normalize liver gene expression, reduce fibrosis, improve detoxification capacity, and extend healthy liver function.
Regulatory & Approval Status
Ovagen is a bioregulator peptide with no documented human clinical trials or FDA approval status; it is primarily available in international markets like Russia.
Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.